ArticleInternational journal of pharmaceutics: X2024

Trastuzumab-functionalized SK-BR-3 cell membrane-wrapped mesoporous silica nanoparticles loaded with pyrotinib for the targeted therapy of HER-2-positive breast cancer.

Xing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.